Searched for
LAURUS LABS INVESTMENT
Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Crorepati investors splurge $1 billion to buy these 10 stocks. Should you follow the smart money?Wealthy investors are making significant moves, pouring over $1 billion into ten select stocks. This concentrated buying occurs even as the...
- Laurus Labs shares jump over 7% after securing land allotment in Andhra PradeshLaurus Labs stock price increased following Andhra Pradesh government's land allotment. The company will establish Laurus Pharma Zone in An...
- Laurus Labs shares zoom 19% to hit new all-time high. Is there more heat left?Laurus Labs surged over 19% in 11 days, hitting a record high of Rs 799.4. Analysts see strong bullish momentum supported by a multi-year b...
- Laurus Labs shares in focus after board approves Rs 83.3 crore investment in KRKA PharmaLaurus Labs has approved an investment of Rs 83.3 crore in the joint venture KRKA Pharma Pvt Ltd to establish a manufacturing facility targ...
- Buy Laurus Labs, target price Rs 710: Bajaj BrokingBajaj Broking recommends buying Laurus Labs with a target price of Rs 710. The current price is Rs 565.4. Laurus Labs expects significant g...
- Laurus Labs biotech unit raises Rs 120 crore from Eight Roads VenturesLaurus Bio has secured ₹120 crore in equity investment from Eight Roads Ventures and F-Prime Capital, with Laurus Labs co-investing ₹40 cro...
- Laurus Labs opens new R&D facility in IKP Knowledge Park, HyderabadLaurus Labs has inaugurated a new R&D facility at IKP Knowledge Park near Hyderabad, investing Rs 250 crore. The 200,000 square foot center...
- Laurus Labs shares rise over 4% as co acquires additional stake in lmmunoACTLaurus Labs is set to increase its stake in Immunoadoptive Cell Therapy (lmmunoACT) by 7.24% for $10.6m, taking its total stake in the comp...
- Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACTThe fresh infusion of capital will enable ImmunoACT to fast-track the scale-up of its lead candidate HCAR-19 by expansion of the multi-loca...
- Buy Laurus Labs, target price Rs 691: Jefferies GroupFor the quarter ended 31-03-2022, the company has reported a Consolidated Total Income of Rs 1426.12 Crore, up 37.91 % from last quarter To...
- ET Emerging Company of the Year 2021: Laurus Labs-A pharma company beats the virus trap to make it bigIt supplies active pharmaceutical ingredients (APIs) to nine out of the 10 largest generic pharma companies and has leadership positions in...
- Buy Laurus Labs, target price Rs 590: Edelweiss SecuritiesLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 29552.08 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 580: Anand RathiLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 27017.93 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 800: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 35388.93 Crore) operating in Pharmaceutica...
- Buy Laurus Labs, target price Rs 800: Motilal OswalLaurus Labs Ltd., incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 36448.72 Crore) operating in Pharmaceutica...
- Trending stocks: Laurus Labs shares rise nearly 1%A total of 73,610 shares changed hands on the counter till 11:32AM (IST).
- Carlyle Group, Advent International in race for Rs 900 crore stake in Laurus LabsPE giant Carlyle Group and Advent International are in discussions for a $150-million (Rs 900-crore) investment deal in Laurus Labs.
Load More
